News

During a visit to a potential partner, the objective was to rapidly assess the feasibility of formulating a poorly soluble compound using Formulite® — and generate material for downstream development without entering a lengthy formulation program. Approach focused, on-site development sprint was conducted over two days, combining feasibility...

We are pleased to welcome Ellen Brunzell to Disruptive Pharma. Ellen is a licensed pharmacist and recently completed her PhD in pharmaceutical physical chemistry at Uppsala University. Her research has focused on drug substances, formulation-relevant interactions and peptide aggregation, bringing valuable expertise to our work in pharmaceutical...